ReviewPharmacology & therapeutics2011

Past, present and future of A(2A) adenosine receptor antagonists in the therapy of Parkinson's disease.

Marie Therese Armentero et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.